Stavish D, Price C, Gelezauskaite G, Alsehli H, Leonhard K, Taapken S
Stem Cell Reports. 2024; 19(8):1217-1232.
PMID: 38964325
PMC: 11368687.
DOI: 10.1016/j.stemcr.2024.06.003.
Srdanovic S, Wolter M, Trinh C, Ottmann C, Warriner S, Wilson A
FEBS J. 2022; 289(17):5341-5358.
PMID: 35286747
PMC: 9541495.
DOI: 10.1111/febs.16433.
Wu J, Lu G, Wang X
Am J Cancer Res. 2022; 11(12):5864-5880.
PMID: 35018230
PMC: 8727814.
Zhou J, Gu L, Shi Y, Huang T, Fan X, Bi X
Cell Mol Life Sci. 2021; 79(1):54.
PMID: 34936032
PMC: 11072236.
DOI: 10.1007/s00018-021-04057-5.
Sanford J, Yang J, Han J, Tollini L, Jin A, Zhang Y
BMC Mol Cell Biol. 2021; 22(1):46.
PMID: 34551723
PMC: 8459461.
DOI: 10.1186/s12860-021-00385-3.
Mechanisms of TP53 Pathway Inactivation in Embryonic and Somatic Cells-Relevance for Understanding (Germ Cell) Tumorigenesis.
Timmerman D, Remmers T, Hillenius S, Looijenga L
Int J Mol Sci. 2021; 22(10).
PMID: 34065345
PMC: 8161298.
DOI: 10.3390/ijms22105377.
Cortical recruitment of centralspindlin and RhoA effectors during meiosis I of primary spermatocytes.
Wang X, Zhang D, Zheng C, Wu S, Glotzer M, Tse Y
J Cell Sci. 2021; 134(3).
PMID: 33468621
PMC: 7888742.
DOI: 10.1242/jcs.238543.
Regulation of p53 by the 14-3-3 protein interaction network: new opportunities for drug discovery in cancer.
Falcicchio M, Ward J, Macip S, Doveston R
Cell Death Discov. 2020; 6(1):126.
PMID: 33298896
PMC: 7669891.
DOI: 10.1038/s41420-020-00362-3.
RBM10, a New Regulator of p53.
Jung J, Lee H, Zeng S, Lu H
Cells. 2020; 9(9).
PMID: 32947864
PMC: 7563659.
DOI: 10.3390/cells9092107.
USP7 Is a Master Regulator of Genome Stability.
Valles G, Bezsonova I, Woodgate R, Ashton N
Front Cell Dev Biol. 2020; 8:717.
PMID: 32850836
PMC: 7419626.
DOI: 10.3389/fcell.2020.00717.
Inhibition of MELK produces potential anti-tumour effects in bladder cancer by inducing G1/S cell cycle arrest via the ATM/CHK2/p53 pathway.
Chen S, Zhou Q, Guo Z, Wang Y, Wang L, Liu X
J Cell Mol Med. 2019; 24(2):1804-1821.
PMID: 31821699
PMC: 6991658.
DOI: 10.1111/jcmm.14878.
Competitive ubiquitination activates the tumor suppressor p53.
Li X, Guo M, Cai L, Du T, Liu Y, Ding H
Cell Death Differ. 2019; 27(6):1807-1818.
PMID: 31796886
PMC: 7244561.
DOI: 10.1038/s41418-019-0463-x.
Estrogens Counteract Platinum-Chemosensitivity by Modifying the Subcellular Localization of MDM4.
Luca R, di Blasio G, Gallo D, Monteleone V, Manni I, Fici L
Cancers (Basel). 2019; 11(9).
PMID: 31547268
PMC: 6770881.
DOI: 10.3390/cancers11091349.
The long and the short of it: the MDM4 tail so far.
Haupt S, Mejia-Hernandez J, Vijayakumaran R, Keam S, Haupt Y
J Mol Cell Biol. 2019; 11(3):231-244.
PMID: 30689920
PMC: 6478121.
DOI: 10.1093/jmcb/mjz007.
Intra molecular interactions in the regulation of p53 pathway.
Chen J
Transl Cancer Res. 2019; 5(6):639-649.
PMID: 30613472
PMC: 6319914.
DOI: 10.21037/tcr.2016.09.23.
MDMX under stress: the MDMX-MDM2 complex as stress signals hub.
de Polo A, Vivekanandan V, Little J, Yuan Z
Transl Cancer Res. 2018; 5(6):725-732.
PMID: 30319942
PMC: 6178224.
DOI: 10.21037/tcr.2016.12.18.
The dynamic and stress-adaptive signaling hub of 14-3-3: emerging mechanisms of regulation and context-dependent protein-protein interactions.
Pennington K, Chan T, Torres M, Andersen J
Oncogene. 2018; 37(42):5587-5604.
PMID: 29915393
PMC: 6193947.
DOI: 10.1038/s41388-018-0348-3.
The fate of murine double minute X (MdmX) is dictated by distinct signaling pathways through murine double minute 2 (Mdm2).
Hauck P, Wolf E, Olivos 3rd D, McAtarsney C, Mayo L
Oncotarget. 2017; 8(61):104455-104466.
PMID: 29262653
PMC: 5732819.
DOI: 10.18632/oncotarget.22320.
The DNA damage response pathway in normal hematopoiesis and malignancies.
Delia D, Mizutani S
Int J Hematol. 2017; 106(3):328-334.
PMID: 28707218
DOI: 10.1007/s12185-017-2300-7.
Regulation of the Mdm2-p53 signaling axis in the DNA damage response and tumorigenesis.
Carr M, Jones S
Transl Cancer Res. 2017; 5(6):707-724.
PMID: 28690977
PMC: 5501481.
DOI: 10.21037/tcr.2016.11.75.